ResMed Inc. · RMD · Next earnings

ResMed Inc. reports Thursday, Jan 28, 2027

RMD reports after market close with consensus EPS at $3.02 and revenue at $1.46B. Last quarter: ResMed reaffirms FY27 outlook as products and digital health support growth

Reports After market close85 days awayDate estimated Healthcare

What the street expects

Consensus for the coming report
Consensus EPS $3.02 Calendar consensus
Consensus revenue $1.46B Calendar consensus
Report date Jan 28, 2027 Thursday, date estimated
Session After market close 85 days away

Where RMD left off: FY2027 Q1

Full report

ResMed reaffirms FY27 outlook as products and digital health support growth

EPS surprise +8.2% Reported $2.91 vs $2.69
Revenue surprise +1.5% Reported $1.41B vs $1.39B
Stock move -9.1% Event window
Subsequent drift 0.0% Up to 20 sessions

No change: FY27 guidance remains 5–7% core constant-currency revenue growth and $12–$12.25 EPS.

What to watch on the call

Carried forward from the last transcript

Risks management flagged

  • Astral ventilator field-safety action and recall-related effects.
  • Inflation in electronic components and foreign-exchange pressure.
  • Potential slowdown after the France fleet-renewal benefit fades.

Questions analysts left open

  • Gross-margin expansion may not progress as quickly as guidance implies.
  • The Astral recall and the end of the France fleet-renewal tailwind could pressure results.
  • Marketing initiatives must translate into durable top-line growth.

Ask FN2 about RMD next report

Transcript, numbers and history already loaded
What should I watch for in RMD's next earnings report?How did RMD guide last quarter, and is consensus above or below that?Give me the bull and bear case going into RMD earnings.

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Get the RMD recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Recent RMD quarters

All RMD earnings
-9.1%FY2027 Q1-5.1%FY2026 Q4-4.1%FY2026 Q3+0.3%FY2026 Q2

Sources

  1. FN2 corporate events calendar, resolved from the earnings calendar feed
  2. FN2 earnings calendar analyst consensus
  3. Earnings call transcript analysis, FY2027 Q1

Methodology

The report date comes from FN2's resolved corporate-events calendar and is marked estimated until the company confirms it. Consensus figures are the calendar's latest analyst estimates for the fiscal period and are not an FN2 forecast.

Risks and open questions are carried forward verbatim from FN2's structured analysis of the previous earnings call. Missing values stay missing and are never estimated.

By FN2 Research · Updated . For educational purposes only; not investment advice.